Infections
|
February 18, 2025

Chagas Disease Insights: Symptoms and Prevention

Written By
Medically Reviewed by
Updated On
March 3, 2025

Imagine being bitten by a tiny insect, only to discover years later that it left behind something far more dangerous than an itchy mark. Chagas disease, caused by the parasite Trypanosoma cruzi, often goes unnoticed for years but can lead to serious health complications. 

This article will guide you through the symptoms, prevention strategies, and holistic approaches to managing Chagas disease, empowering you with the knowledge to take proactive steps toward your health.

[signup]

What is Chagas Disease?

Chagas disease is a potentially serious illness caused by the parasite Trypanosoma cruzi. It primarily affects the heart and digestive system and can remain undetected for years before symptoms appear. The disease progresses in two phases: an acute stage with mild or no symptoms and a chronic stage that may lead to severe complications.

Understanding Trypanosoma cruzi

Trypanosoma cruzi is a microscopic parasite transmitted to humans through insect bites, contaminated food, blood transfusions, organ transplants, or from mother to baby during pregnancy. Once inside the body, the parasite multiplies and spreads, primarily targeting the heart and other organs.

Transmission Methods

Chagas disease spreads through several routes, including:

Epidemiology

Chagas disease affects an estimated 6–7 million people worldwide, mainly in Latin America. While Chagas disease is most common in Latin America, migration has led to sporadic cases in other regions. However, the risk of transmission remains low in non-endemic areas with proper screening and preventive measures.

High-Risk Regions

  • Latin America (Bolivia, Argentina, Brazil, Mexico, and Colombia have the highest case numbers)
  • Rural areas with poor housing conditions, where kissing bugs thrive
  • Urban centers where migration has introduced cases through blood transfusions and organ donations
  • Southern U.S. (cases detected in Texas, Arizona, and California, though risk remains low)

Understanding these risks is key to preventing Chagas disease and protecting vulnerable communities.

Symptoms and Diagnosis

Recognizing Chagas disease symptoms and obtaining an accurate diagnosis are essential steps in managing the infection and preventing complications.

Acute vs. Chronic Symptoms

Chagas disease develops in two phases: the acute stage, which occurs shortly after infection, and the chronic stage, which can take years to show symptoms. Each stage affects the body differently.

Acute Stage (First Weeks to Months)

Most cases in the acute phase are mild or asymptomatic. When symptoms do appear, they may include:

  • Fever and fatigue
  • Swelling around the bite site (Romaña’s sign—a swollen eyelid)
  • Headache and body aches
  • Nausea, vomiting, or diarrhea
  • Enlarged liver or spleen

Symptoms usually fade within weeks, but the parasite remains in the body, potentially leading to chronic infection.

Chronic Stage (Years to Decades Later)

Many people enter a silent phase with no symptoms for years. However, 20–30% of infected individuals eventually develop serious complications, such as:

Early-Stage Indicators

Recognizing symptoms early can help prevent long-term damage. Warning signs include:

  • Persistent fatigue
  • Unexplained swelling or inflammation
  • Irregular heartbeat or chest pain
  • Difficulty digesting food or chronic bloating

Diagnostic Methods

Doctors use a combination of lab tests and imaging to detect Trypanosoma cruzi infection and assess its impact on the body.

Laboratory Tests

  • Blood tests: Detect antibodies or parasite DNA
  • Microscopy: Identifies parasites in blood samples (useful in acute phase)
  • Polymerase Chain Reaction (PCR): Confirms parasite DNA, especially in early infection. PCR testing is most effective for detecting early-stage infections, while antibody tests are more reliable for chronic cases.

Imaging Techniques

Early diagnosis is essential to managing Chagas disease and preventing severe complications. Understanding the symptoms and available tests can help individuals seek timely medical care.

Conventional Medical Treatments

Chagas disease treatment aims to eliminate the parasite in the early stages and manage complications in chronic cases. While antiparasitic medications are the standard approach, additional care may be needed for those with long-term health effects.

Antiparasitic Medications

Medications that target Trypanosoma cruzi can help reduce the parasite burden and slow disease progression, especially when administered early.

Benznidazole and Nifurtimox are FDA-approved for treating Chagas disease, particularly in the acute phase. They attack the parasite but are most effective during the acute phase. In chronic cases, they may help reduce disease progression but are less reliable. 

Side effects, such as nausea, headaches, and allergic reactions, can sometimes make treatment difficult.

Treatment Efficacy and Challenges

Although antiparasitic medications can help, they do not always guarantee full parasite clearance. Effectiveness depends on the stage of infection, and challenges such as limited drug availability and side effects can impact treatment success.

Managing Complications

Treatment focuses on addressing complications affecting the heart and digestive system for those in the chronic phase.

Cardiovascular Treatments

Chronic Chagas disease can lead to heart problems, including irregular heartbeats, heart failure, and an increased risk of sudden cardiac arrest. Treatment may involve medications, pacemakers, or even heart transplants in advanced cases, depending on the severity.

Gastrointestinal Interventions

Some individuals develop digestive complications, such as difficulty swallowing or severe constipation, due to nerve damage in the digestive tract. Treatments range from dietary adjustments and medications to surgical procedures in severe cases.

Early detection and proper management of complications can improve the quality of life and reduce the risk of severe outcomes for individuals with Chagas disease.

Holistic and Integrative Approaches

Many individuals explore holistic and integrative strategies in addition to conventional treatments to support their overall well-being. These complementary approaches may support overall well-being but should not replace antiparasitic medications or conventional treatments.

Nutrition and Lifestyle

A well-balanced diet and healthy daily habits can support immune function and reduce inflammation, potentially easing some of the long-term effects of Chagas disease.

Dietary Recommendations

Nutrient-dense foods rich in antioxidants, fiber, and healthy fats may promote cardiovascular and digestive health. Limiting processed foods, excessive sugar, and unhealthy fats can further support the body's ability to maintain balance.

Physical Activity and Wellness

Regular movement and exercise support heart function and overall vitality. However, individuals with cardiac complications should follow medical guidance on safe activity levels.

Alternative Therapies

Some individuals turn to complementary therapies to help manage symptoms and improve quality of life alongside conventional care.

Herbal Supplements

Certain plant-based supplements are being studied for their potential to support immune function and cardiovascular health. However, more research is needed, and it's important to consult a healthcare provider before using alternative remedies.

Mind-Body Practices

Stress management techniques, such as meditation, yoga, acupuncture, and breathing exercises, may help individuals cope with chronic illness, reduce stress, and improve overall well-being.

Consult a healthcare provider before starting any alternative therapies to ensure they are safe and appropriate.

Functional Medicine Strategies

Functional medicine takes a personalized approach by addressing underlying imbalances and optimizing long-term health.

Personalized Treatment Plans

Healthcare providers in functional medicine may tailor treatment strategies based on genetic, environmental, and lifestyle factors to create a comprehensive care plan.

Addressing Root Causes

Instead of just managing symptoms, functional medicine focuses on strengthening the body's resilience by improving gut health, reducing inflammation, and enhancing immune function.

By combining conventional, holistic, and functional approaches, individuals with Chagas disease can explore a well-rounded plan to support their health and improve their quality of life.

Prevention and Public Health Strategies

Preventing Chagas disease requires a combination of personal protection, community interventions, and public health initiatives. Since the disease spreads primarily through insect bites and contaminated materials, efforts focus on reducing exposure to Trypanosoma cruzi and controlling its transmission.

Vector Control and Housing Improvements

Triatomine bugs, also known as "kissing bugs," are the main carriers of Chagas disease. Reducing their presence in homes and surrounding areas is a key prevention strategy.

  • Using insecticides to eliminate bugs in high-risk areas
  • Improving housing conditions, such as sealing cracks in walls and roofs
  • Using bed nets and protective screens to reduce nighttime bites

Personal Protection Measures

Individuals living in or traveling to endemic areas can take additional steps to reduce their risk of infection.

  • Sleeping in well-screened or air-conditioned rooms
  • Using insect repellent and protective clothing in areas where kissing bugs are common
  • Avoiding consumption of unpasteurized juices or foods that may be contaminated with the parasite

Screening and Early Detection

Testing at-risk populations is essential for early diagnosis and treatment, especially for individuals in endemic regions or those who may have acquired the infection through blood transfusion or congenital transmission.

  • Screening pregnant women in high-risk areas to prevent mother-to-child transmission
  • Testing blood and organ donors to prevent transmission through transfusion or transplant
  • Encouraging early testing for individuals who may have been exposed through travel or living conditions

Community Education and Awareness

Raising awareness about Chagas disease helps individuals and communities take preventive measures and seek timely medical care.

  • Public health campaigns to educate communities on how the disease spreads and how to prevent it
  • Training healthcare workers to recognize early symptoms and improve diagnosis rates
  • Encouraging research and policy initiatives to improve treatment access and disease control

Combining individual precautions with large-scale public health efforts can reduce the spread of Chagas disease, and more people can receive early diagnosis and care.

Living with Chagas Disease

A Chagas disease diagnosis can feel overwhelming, but with the right care and lifestyle adjustments, individuals can manage their condition and maintain a good quality of life. While some may never experience severe symptoms, others may need ongoing medical support to address heart or digestive complications.

Medical Management and Follow-Up Care

Regular medical check-ups are important for monitoring disease progression and managing any complications. A healthcare provider may recommend:

  • Periodic heart and digestive system evaluations to detect early changes
  • Medications to help manage symptoms, such as antiarrhythmics for heart irregularities
  • Lifestyle modifications to support heart and gut health

Emotional and Mental Well-Being

Chronic illnesses can take an emotional toll, making mental health support just as important as physical care. Strategies for coping include:

  • Seeking support groups or counseling for emotional well-being
  • Practicing stress management techniques, such as meditation, yoga, or deep breathing
  • Staying informed about the condition to feel empowered in managing health decisions

[signup]

Key Takeaways

  • Chagas disease is caused by Trypanosoma cruzi and can progress from an acute phase with mild symptoms to a chronic phase with serious heart and digestive complications.
  • Early diagnosis through blood tests and imaging can help manage the disease, but treatment effectiveness depends on the stage of infection.
  • Antiparasitic medications like benznidazole and nifurtimox are most effective in the early stage, while chronic cases focus on managing complications.
  • Prevention strategies include vector control, improved housing, personal protection, and routine screening for at-risk individuals.
  • A holistic approach, including medical care, nutrition, stress management, and lifestyle adjustments, can support long-term well-being for those living with Chagas disease.
The information in this article is designed for educational purposes only and is not intended to be a substitute for informed medical advice or care. This information should not be used to diagnose or treat any health problems or illnesses without consulting a doctor. Consult with a health care practitioner before relying on any information in this article or on this website.

Learn more

No items found.

Lab Tests in This Article

No lab tests!

Abud, T. G., Abud, L. G., Vilar, V. S., Szejnfeld, D., & Reibscheid, S. (2016). Radiological findings in megaesophagus secondary to Chagas disease: chest X-ray and esophagogram. Radiologia Brasileira, 49(6), 358–362. https://doi.org/10.1590/0100-3984.2015.0141

Andrade, D. V., Gollob, K. J., & Dutra, W. O. (2014). Acute Chagas Disease: New Global Challenges for an Old Neglected Disease. PLoS Neglected Tropical Diseases, 8(7), e3010. https://doi.org/10.1371/journal.pntd.0003010

Angheben, A., Boix, L., Buonfrate, D., Gobbi, F., Bisoffi, Z., Pupella, S., Gandini, G., & Aprili, G. (2015). Chagas disease and transfusion medicine: a perspective from non-endemic countries. Blood Transfusion = Trasfusione Del Sangue, 13(4), 540–550. https://doi.org/10.2450/2015.0040-15

Bautista-Lopez, N., & Momar Ndao. (2024). Usefulness of polymerase chain reaction tests in Chagas disease studies. Frontiers in Parasitology, 3. https://doi.org/10.3389/fpara.2024.1292143

Beucler, N., Torrico, F., & Hibbert, D. (2020). A tribute to Cecilio Romaña: Romaña’s sign in Chagas disease. PLOS Neglected Tropical Diseases, 14(11), e0008836. https://doi.org/10.1371/journal.pntd.0008836

Brito, B. O. de F., & Ribeiro, A. L. P. (2018). Electrocardiogram in Chagas disease. Revista Da Sociedade Brasileira de Medicina Tropical, 51(5), 570–577. https://doi.org/10.1590/0037-8682-0184-2018

Budnick, L. D., Bocco, B. W., & Montgomery, S. P. (2019). Work-Related Trypanosoma cruzi Exposures. Journal of Occupational & Environmental Medicine, 61(10), e429–e431. https://doi.org/10.1097/jom.0000000000001674

Carlier, Y., Altcheh, J., Angheben, A., Freilij, H., Luquetti, A. O., Schijman, A. G., Segovia, M., Wagner, N., & Albajar Vinas, P. (2019). Congenital Chagas disease: Updated recommendations for prevention, diagnosis, treatment, and follow-up of newborns and siblings, girls, women of childbearing age, and pregnant women. PLOS Neglected Tropical Diseases, 13(10), e0007694. https://doi.org/10.1371/journal.pntd.0007694

Castro, J. A., & Diaz de Toranzo, E. G. (1988). Toxic effects of nifurtimox and benznidazole, two drugs used against American trypanosomiasis (Chagas’ disease). Biomedical and Environmental Sciences: BES, 1(1), 19–33. https://pubmed.ncbi.nlm.nih.gov/3151755/

Castro-Arroyave, D., Monroy, M. C., & Irurita, M. I. (2020). Integrated vector control of Chagas disease in Guatemala: a case of social innovation in health. Infectious Diseases of Poverty, 9(1). https://doi.org/10.1186/s40249-020-00639-w

CDC. (2019). CDC - DPDx - American Trypanosomiasis. Centers for Disease Control and Prevention. https://www.cdc.gov/dpdx/trypanosomiasisamerican/index.html

CDC. (2024a, February 9). Clinical Testing and Diagnosis for Chagas Disease. Parasites - American Trypanosomiasis (Also Known as Chagas Disease). https://www.cdc.gov/chagas/hcp/diagnosis-testing/index.html

CDC. (2024b, February 9). Preventing Chagas Disease. Parasites - American Trypanosomiasis (Also Known as Chagas Disease). https://www.cdc.gov/chagas/prevention/index.html

CDC. (2024c, April 26). Chagas Disease. Chagas Disease. https://www.cdc.gov/chagas/index.html

CDC. (2024d, June 24). Chagas Disease Resources. Chagas Disease. https://www.cdc.gov/chagas/php/resources/index.html

Chagas Disease: Causes, Symptoms, Treatment & Prevention. (n.d.). Cleveland Clinic. https://my.clevelandclinic.org/health/diseases/21876-chagas-disease

Cloyd, J. (2023a, July 3). The Role of Physical Activity in Promoting Heart Health. Rupa Health. https://www.rupahealth.com/post/the-role-of-physical-activity-and-exercise-in-promoting-heart-health-including-the-use-of-alternative-exercise-modalities-such-as-tai-chi-and-qigong

Cloyd, J. (2023b, October 9). Rhythms of the Heart: Demystifying Common Types of Heart Arrhythmia. Rupa Health. https://www.rupahealth.com/post/rhythms-of-the-heart-demystifying-common-types-of-heart-arrhythmia

Cloyd, J. (2024, December 16). 6 Warning Signs of a Heart Attack a Month Before It Happens. Rupa Health. https://www.rupahealth.com/post/6-potential-warning-signs-of-a-heart-attack-before-it-happens

Colussi, C., Stafuza, M., Nepote, M., & Mendicino, D. (n.d.). Seroprevalence of Chagas disease in urban and rural indigenous populations of the south of Gran Chaco. Revista Da Sociedade Brasileira de Medicina Tropical, 55, e0479-2021. https://doi.org/10.1590/0037-8682-0479-2021

Coura, J. R. (2014). The main sceneries of Chagas disease transmission. The vectors, blood and oral transmissions - A comprehensive review. Memórias Do Instituto Oswaldo Cruz, 110(3), 277–282. https://doi.org/10.1590/0074-0276140362

Coura, J. R., & Borges-Pereira, J. (2011). Chronic phase of Chagas disease: why should it be treated? A comprehensive review. Memórias Do Instituto Oswaldo Cruz, 106(6), 641–645. https://doi.org/10.1590/s0074-02762011000600001

Edwards, M. S., Stimpert, K. K., & Montgomery, S. P. (2017). Addressing the Challenges of Chagas Disease. Infectious Diseases in Clinical Practice, 25(3), 118–125. https://doi.org/10.1097/ipc.0000000000000512

Forsyth, C. J., Hernandez, S., Olmedo, W., Abuhamidah, A., Traina, M. I., Sanchez, D. R., Soverow, J., & Meymandi, S. K. (2016). Safety Profile of Nifurtimox for Treatment of Chagas Disease in the United States. Clinical Infectious Diseases, 63(8), 1056–1062. https://doi.org/10.1093/cid/ciw477

Forsyth, C. J., Manne-Goehler, J., Bern, C., Whitman, J., Hochberg, N. S., Edwards, M., Marcus, R., Beatty, N. L., Castro, Y., Coyle, C., Stigler-Granados, P., Hamer, D., Maguire, J. H., Gilman, R., & Meymandi, S. (2021). Recommendations for Screening and Diagnosis of Chagas Disease in the United States. The Journal of Infectious Diseases, 225(9). https://doi.org/10.1093/infdis/jiab513

Greenan, S. (2021, November 19). What is Functional Medicine? How Do I Find A Functional Medicine Practitioner? Rupa Health. https://www.rupahealth.com/post/what-is-functional-medicine

Hopkins. (n.d.). Chagas Disease. Www.hopkinsmedicine.org. https://www.hopkinsmedicine.org/health/conditions-and-diseases/chagas-disease

Kirchhoff, L. V., Votava, J. R., Ochs, D. E., & Moser, D. R. (1996). Comparison of PCR and microscopic methods for detecting Trypanosoma cruzi. Journal of Clinical Microbiology, 34(5), 1171–1175. https://doi.org/10.1128/jcm.34.5.1171-1175.1996

Losada Galván, I., Alonso-Padilla, J., Cortés-Serra, N., Alonso-Vega, C., Gascón, J., & Pinazo, M. J. (2020). Benznidazole for the treatment of Chagas disease. Expert Review of Anti-Infective Therapy, 1–10. https://doi.org/10.1080/14787210.2021.1834849

Lynn, M. K., Bossak, B. H., Sandifer, P. A., Watson, A., & Nolan, M. S. (2020). Contemporary autochthonous human Chagas disease in the USA. Acta Tropica, 205, 105361. https://doi.org/10.1016/j.actatropica.2020.105361

Maholy, N. (2023, April 14). How to reduce stress through mind-body therapies. Rupa Health. https://www.rupahealth.com/post/how-to-reduce-stress-through-mind-body-therapies

Matsuda, N. M., Miller, S. M., & Evora, P. R. B. (2009). The chronic gastrointestinal manifestations of Chagas disease. Clinics, 64(12), 1219–1224. https://doi.org/10.1590/s1807-59322009001200013

Mayo Clinic. (2020, November 12). Chagas disease - Symptoms and causes. Mayo Clinic. https://www.mayoclinic.org/diseases-conditions/chagas-disease/symptoms-causes/syc-20356212

Neibling, K. (2023, February 27). Integrative medicine treatment for headaches. Rupa Health. https://www.rupahealth.com/post/integrative-medicine-treatment-for-headaches

Nepomuceno, G., Pau Bosch-Nicolau, Nascimento, B. R., Martins-Melo, F. R., Perel, P., Geissbühler, Y., Demacq, C., Quijano, M., Mosser, J. F., Cousin, E., Machado, Í. E., Matheus, Luiz, A., & Molina, I. (2024). Prevalence of Chagas disease among Latin American immigrants in non-endemic countries: an updated systematic review and meta-analysis. The Lancet Regional Health - Europe, 46, 101040–101040. https://doi.org/10.1016/j.lanepe.2024.101040

Nguyen, T., & Waseem, M. (2020). Chagas Disease (American Trypanosomiasis). PubMed; StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK459272/

Nunes, M. C. P., Beaton, A., Acquatella, H., Bern, C., Bolger, A. F., Echeverría, L. E., Dutra, W. O., Gascon, J., Morillo, C. A., Oliveira-Filho, J., Ribeiro, A. L. P., & Marin-Neto, J. A. (2018). Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management: A Scientific Statement From the American Heart Association. Circulation, 138(12). https://doi.org/10.1161/cir.0000000000000599

Olivo-Freites, C., Sy, H., Cardenas-Alvarez, J., Vega-Batista, F., & Henao-Martínez, A. F. (2023). Trypanosoma cruzi Central Nervous System Infection—Pathogenesis, Clinical Manifestations, Diagnosis, and Treatment. Current Tropical Medicine Reports. https://doi.org/10.1007/s40475-023-00300-0

Porta, J., Kalesh, K. A., & Steel, P. G. (2023). Navigating drug repurposing for Chagas disease: advances, challenges, and opportunities. Frontiers in Pharmacology, 14. https://doi.org/10.3389/fphar.2023.1233253

Ralston, K., Zaidel, E., Acquatella, H., Marcia Melo Barbosa, Narula, J., Nakagama, Y., Gustavo Restrepo Molina, Sliwa, K., Jose Luis Zamorano, Pinto, F. J., Daniel Jose Piñeiro, & Corneli, M. (2023). WHF Recommendations for the Use of Echocardiography in Chagas Disease. Global Heart, 18(1). https://doi.org/10.5334/gh.1207

Rassi, A., J.M. de Rezende, A.O. Luquetti, & Rassi, A. (2017). Clinical phases and forms of Chagas disease. Elsevier EBooks, 653–686. https://doi.org/10.1016/b978-0-12-801029-7.00029-0

Saraiva, R. M., Mediano, M. F. F., Mendes, F. S., Sperandio da Silva, G. M., Veloso, H. H., Sangenis, L. H. C., Silva, P. S. da, Mazzoli-Rocha, F., Sousa, A. S., Holanda, M. T., & Hasslocher-Moreno, A. M. (2021). Chagas heart disease: An overview of diagnosis, manifestations, treatment, and care. World Journal of Cardiology, 13(12), 654–675. https://doi.org/10.4330/wjc.v13.i12.654

Stanford, J. (2024, July 15). The Top 10 Most Nutrient-Dense Foods: Boost Your Health with These Powerhouses. Rupa Health. https://www.rupahealth.com/post/top-nutrient-dense-foods

Stigler Granados, P., Pacheco, G. J., Núñez Patlán, E., Betancourt, J., & Fulton, L. (2020). Assessing the effectiveness of Chagas disease education for healthcare providers in the United States. BMC Infectious Diseases, 20(1). https://doi.org/10.1186/s12879-020-05474-w

Suárez, C., Nolder, D., García-Mingo, A., Moore, D. A., & Chiodini, P. L. (2022). Diagnosis and Clinical Management of Chagas Disease: An Increasing Challenge in Non-Endemic Areas. Research and Reports in Tropical Medicine, Volume 13, 25–40. https://doi.org/10.2147/rrtm.s278135

Teeter, L. A. (2023, April 3). Mental health benefits of yoga and meditation. Rupa Health. https://www.rupahealth.com/post/mental-health-benefits-of-yoga-and-meditation

World Health Organization. (2024, April 4). Chagas disease (American trypanosomiasis). Who.int; World Health Organization: WHO. https://www.who.int/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis)

Yoshimura, H. (2023, August 1). A Comprehensive Guide to Nutrition and Supplements for Supporting Detoxification Pathways. Rupa Health. https://www.rupahealth.com/post/a-comprehensive-guide-to-nutrition-and-supplements-for-supporting-detoxification-pathways

Yoshimura, H. (2024, April 12). Nutritional interventions in heart failure care. Rupa Health. https://www.rupahealth.com/post/nutritional-interventions-in-heart-failure-care

Order from 30+ labs in 20 seconds (DUTCH, Mosaic, Genova & More!)
We make ordering quick and painless — and best of all, it's free for practitioners.

Latest Articles

View more on Infections
Subscribe to the magazine for expert-written articles straight to your inbox
Join the thousands of savvy readers who get root cause medicine articles written by doctors in their inbox every week!
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Subscribe to the Magazine for free to keep reading!
Subscribe for free to keep reading, If you are already subscribed, enter your email address to log back in.
Thanks for subscribing!
Oops! Something went wrong while submitting the form.
Are you a healthcare practitioner?
Thanks for subscribing!
Oops! Something went wrong while submitting the form.

Hey practitioners! 👋 Join Dr. Chris Magryta and Dr. Erik Lundquist for a comprehensive 6-week course on evaluating functional medicine labs from two perspectives: adult and pediatric. In this course, you’ll explore the convergence of lab results across different diseases and age groups, understanding how human lab values vary on a continuum influenced by age, genetics, and time. Register Here! Register Here.